BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/26/2023 9:50:16 AM | Browse: 186 | Download: 636
 |
Received |
|
2022-10-09 12:29 |
|
Peer-Review Started |
|
2022-10-09 12:30 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-12-13 05:08 |
|
Revised |
|
2022-12-22 08:57 |
|
Second Decision |
|
2023-04-04 03:27 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-04-04 08:29 |
|
Articles in Press |
|
2023-04-04 08:29 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2023-04-02 18:42 |
|
Typeset the Manuscript |
|
2023-05-17 06:03 |
|
Publish the Manuscript Online |
|
2023-05-26 09:50 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
CD4+CD25+ regulatory T cells decreased future liver remnant after associating liver partition and portal vein ligation for staged hepatectomy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wei Wang, Chun-Hui Ye, Zhen-Feng Deng, Ji-Long Wang, Ling Zhang, Li Bao, Bang-Hao Xu, Hai Zhu, Ya Guo and Zhang Wen |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
8190111624 |
| Guangxi Natural Science Foundation of China |
2018JJB140382 |
| Guangxi University Young and Middle-Aged Teachers’ Basic Scientific Research Ability Improvement Project |
2019KY0123 |
|
| Corresponding Author |
Zhang Wen, MD, PhD, Chief Doctor, Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, No. 6, Shuangyong Road, Nanning 530021, Guangxi Zhuang Autonomous Region, China. wenzgxmu@163.com |
| Key Words |
Associating liver partition and portal vein ligation for staged hepatectomy; Regulatory T cells; Future liver remnant |
| Core Tip |
To investigate the mechanisms affecting future liver remnant (FLR) after stage 1 associating liver partition and portal vein ligation for staged hepatectomy (ALPPS), this study was conducted by analyzing clinical data and peripheral blood specimens collected from hepatocellular carcinoma patients treated with ALPPS. The results showed that CD4+CD25+ regulatory T cells (Tregs) in peripheral blood after stage 1 ALPPS was negatively correlated with the index of FLR regeneration after stage 1 ALPPS and may influence the extent of liver fibrosis in patients. The percentage of Tregs was highly accurate in predicting FLR regeneration after stage 1 ALPPS. |
| Publish Date |
2023-05-26 09:50 |
| Citation |
Wang W, Ye CH, Deng ZF, Wang JL, Zhang L, Bao L, Xu BH, Zhu H, Guo Y, Wen Z. CD4+CD25+ regulatory T cells decreased future liver remnant after associating liver partition and portal vein ligation for staged hepatectomy. World J Gastrointest Surg 2023; 15(5): 917-930 |
| URL |
https://www.wjgnet.com/1948-9366/full/v15/i5/917.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v15.i5.917 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
